Stock Alert: Mersana Shares Hit New 52-Week High

Shares of Mersana Therapeutics Inc. (MRSN) hit a new 52-week high of $23.40 on Friday, May 29, before closing at $22.64, up $2.95 or 14.98%. The stock, further, gained 36 cents or 1.59% in the extended trading session on Friday. Trading volume surged to 9.85 million versus an average volume of 2.01 million shares. Most recently on May 28, the […]

Read more

Gemini Exchange Brings Crypto Trading to Over 4 Million Samsung Users in U.S., Canada | BTCMANAGER

Winklevoss brothers-backed Gemini cryptocurrency exchange has inked a partnership with South Korean multinational conglomerate Samsung Electronics Co. Per the terms of the partnership, as reported by Bloomberg on May 28, 2020, Gemini’s app will integrate with Samsung’s blockchain wallet to allow users to trade and store digital assets on mobile phones. Gemini Partners Samsung Blockchain Wallet In a bid to […]

Read more

Bitcoin Could Hit $11,000 in June 2020; Here's Why

Bitcoin is correcting lower after testing $10,000 as its local top. But a confluence of technical and fundamental catalysts could flip the cryptocurrency’s direction towards $11,000. They include a Symmetrical Triangle formation, the Sino-U.S. geopolitical conflict, and the Federal Reserve’s unlimited fiscal support. Bitcoin is correcting lower in the final week of May but its likelihood of retesting levels above […]

Read more

Renault Plans To Cut About 14,600 Jobs Worldwide

Groupe Renault plans to cut about 14,600 jobs across the world and lower its production capacity. The plan includes almost 4,600 jobs reduction in France, through voluntary retirement and retraining, the company said in a statement. More than 10,000 positions in the rest of the world will be eliminated. The French carmaker said, “The difficulties encountered by the Group, the […]

Read more

ABIO Jumps On Joining COVID-19 Drug Fray, GMAB Hits Trial Goal, IMRA On Watch

Today’s Daily Dose brings you news about ARCA biopharma joining the battle against COVID-19; Genmab’s positive results from amyloidosis trial; MacroGenics’ regulatory update related to breast cancer drug candidate Margetuximab and Simulations Plus receiving the FDA grant award. Read on… 1. ARCA Jumps Into COVID-19 Drug Fray; Stock Explodes Over 300% ARCA biopharma Inc. (ABIO) has decided to evaluate AB201, […]

Read more
1 2 3 4 274